Pathology in most chronic inflammatory diseases is characterized by an imbalance in cytokine expression. Targeting cytokines with monoclonal antibodies has proven to be a highly effective treatment. However, monoclonal antibody therapy has disadvantages such as high production costs, generation of antimonoclonal antibodies and the inconvenience of frequent injections. Therapeutic vaccines have the potential to overcome these limitations. The aim of active vaccination is to induce B-cell respo...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines.
If you are the owner of this record, you can report an update to it here: Report update to this record